SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway.
SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway.
复制标题
DOI:
10.1016/j.isci.2021.102295
复制
发表时间:
2021-04-23
期刊:
影响因子:
5.8
通讯作者:
Spector SA
中科院分区:
文献类型:
--
作者:
Campbell GR;To RK;Hanna J;Spector SA
Macrophages promote an early host response to infection by releasing pro-inflammatory cytokines such as interleukin-1β (IL-1β), TNF, and IL-6. The bioactivity of IL-1β is classically dependent on NLRP3 inflammasome activation, which culminates in caspase-1 activation and pyroptosis. Recent studies suggest a role for NLRP3 inflammasome activation in lung inflammation and fibrosis in both COVID-19 and SARS, and there is evidence of NLRP3 involvement in HIV-1 disease. Here, we show that GU-rich single-stranded RNA (GU-rich RNA) derived from SARS-CoV-2, SARS-CoV-1, and HIV-1 trigger a TLR8-dependent pro-inflammatory cytokine response from human macrophages in the absence of pyroptosis, with GU-rich RNA from the SARS-CoV-2 spike protein triggering the greatest inflammatory response. Using genetic and pharmacological inhibition, we show that the induction of mature IL-1β is through a non-classical pathway dependent on caspase-1, caspase-8, the NLRP3 inflammasome, potassium efflux, and autophagy while being independent of TRIF (TICAM1), vitamin D3, and pyroptosis. GU-rich ssRNA induces IL-1β, TNF, and IL-6 from human macrophages through TLR8 SARS-CoV-2 RNA elicits a greater inflammatory response than SARS-CoV-1 or HIV-1 RNA SARS-CoV-2 RNA elicits TLR8-mediated IL-1β production in the absence of pyroptosis TLR8-mediated IL-1β release is dependent on CASP8, K+ efflux, NLRP3, and autophagy Immunology; Virology
登录
查看更多内容
影响因子:
6.7
作者:
Campbell GR;Spector SA
通讯作者:
Spector SA
影响因子:
32.4
作者:
Evavold CL;Ruan J;Tan Y;Xia S;Wu H;Kagan JC
通讯作者:
Kagan JC
影响因子:
8.7
作者:
Elliott EI;Sutterwala FS
通讯作者:
Sutterwala FS
DOI:
10.1016/s0140-6736(08)61113-7
发表时间:
2008-07-26
期刊:
Lancet (London, England)
影响因子:
--
作者:
Antiretroviral Therapy Cohort Collaboration
通讯作者:
Antiretroviral Therapy Cohort Collaboration
影响因子:
12.4
作者:
Conos, S. A.;Lawlor, K. E.;Lindqvist, L. M.
通讯作者:
Lindqvist, L. M.